Merck KGAA O.N. (MRCG)

167.40 -0.35 (-0.21%)
Close EUR Disclaimer

Merck KGAA O.N. Company Profile

Industry
Pharmaceuticals
Sector
Healthcare
Employees
62908
Equity Type
ORD
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies. Its Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software. The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions. In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KGaA.
Contact Information
Address
Darmstadt,64293 Germany
Phone
49 6151 72 0
Fax
49 6151 72 2000
Top Executives
Name
Age
Since
Title
Michael Kleinemeier 66 2019 Independent Chairman of Supervisory Board
Sascha Held 42 2019 Vice Chair of Supervisory Board
Barbara Lambert 62 2023 Independent Member of Supervisory Board
Dietmar Oeter 58 2014 Independent Member of Supervisory Board
Simon Thelen 0 2019 Independent Member of Supervisory Board
Anne Lange 0 2019 Independent Member of Supervisory Board
Christian Raabe 0 2019 Independent Member of Supervisory Board
Daniel Thelen 0 2019 Independent Member of Supervisory Board
Carla Kriwet 53 2024 Supervisory Board Member
Birgit Biermann 51 2022 Member of Supervisory Board
Katja Garcia Vila 52 2024 Supervisory Board Member
Susanne Schaffert 57 2024 Supervisory Board Member
Michael Reinhart 45 2024 Supervisory Board Member
Stefan Palzer 55 2024 Supervisory Board Member
Sandra Schwebke 53 2024 Supervisory Board Member
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles